Don't qualify for this program? Visit the DBAs to look for financial assistance based on your diagnosis.  
 

Johnson & Johnson Patient Assistance Foundation, Inc. Hospital Access Patient Assistance Program

This program provides medication at no cost.

Provided by: Johnson & Johnson Patient Assistance Foundation, Inc.


TEL: 800-652-6227


Languages Spoken:

English

Program Website

 

Patient Assistance Applications

Johnson & Johnson Hospital Access Patient Assistance Program Application: Contact program

 

Brand Name Medications

 
  • Edurant tablet
  • Prezcobix tablet
  • Intelence tablet
  • Prezista tablet
  • Invokamet tablet
  • Symtuza tablet
  • Invokamet XR tablet; extended release
  • Xarelto tablet
  • Invokana tablet
 

Generic Name Medications

 
  • canagliflozin tablet
  • darunavir/cobicistat/emtricitabine/tenofovir alafenamide tablet
  • canagliflozin/metformin tablet
  • etravirine tablet
  • canagliflozin/metformin tablet; extended release
  • rilpivirine tablet
  • darunavir tablet
  • rivaroxaban tablet
  • darunavir/cobicistat tablet
 

Eligibility Requirements   

Insurance Status Contact program for details.
Those with Part D Eligible? Not specified
Income Not applicable
Diagnosis/Medical Criteria Not applicable
US Residency Required? Must be residing in the US or US territory
   

Application

Obtaining Enroll online
Receiving Must apply online
Returning Not applicable
Doctor's Action Hospital must complete product request form for each replacement
Applicant's Action Not specified
Decision Communicated Not specified
Decision Timeframe Not specified
   

Medication

Amount/Supply Not specified
Sent To Hospital
Delivery Time Not specified
Refill Process Not specified
Limit Not specified
Re-application New application, new documentation yearly
   

Additional Information

This program allows eligible hospitals to receive free medications to give to qualified outpatients directly.

Contact the program for more details (1-800-652-6227).

The hospital access application is only available via the online portal.


Updated October 18, 2022